None listed
Conditions
Interventions
Medical Device : Participants (n=20) are randomly assigned to gait training with tDCS group (n=10) and gait training with sham stimulation group (n=10). All groups receive treatment 3 times per week f
Sponsors
Chonnam National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged from 20 to 90 years 2) 3 months after ischemic stroke onset 3) hemiplegic patient 4) Functional ambulatory category grade 2~4 5) No difficulty in understanding and communicating with physical therapist 6) Who voluntarily signed an informed consent form for participation in clinical trial
Exclusion criteria
Exclusion criteria: 1) Who is diagnosed or accompanied with stroke other than ischemic type (e.g. hemorrhagic stroke) 2) Who has gait and balance disturbance due to disease other than stroke (e.g. Parkinsonism, neuropathy, myopathy, arthropathy) 3) Who has experienced a seizure or get ongoing treatment for epilepsy 4) Who received medication, procedure or surgery that may affect gait function in last 1 month 5) Who has medical and surgical condition at electrode attachment site 6) Unstable vital signs 7) Who get ongoing treatment for malignancy 8) Who has severe depression and psychiatric disorders that is difficult to adapt the treatment 9) Contraindications to electrostimulation (1) Metal in head (except in oral cavity) - cochlear implants, electrode or stimulator, clips or coils for aneurysm, stents, bullet fragments, deep brain stimulator, vagus nerve stimulator, eyeball implant (2) Who has pacemaker, defibrillator, neurostimulator, drug pump, intracardiac injection line (3) Who shows continuos seizure event (4) Who received craniectomy, or ventriculo peritoneal shunt (VP shunt) surgery (5) Who continuously complains of elevated intracranial pressure symptoms such as headache, vomiting or nausea and others 10) Who has difficulty in communication due to severe aphasia 11) Who has cognitive decline that is difficult to adapt the treatment (Clinical Dementia Rating 1 or more) 12) If other treatments that may affect gait function are performed during the study 13) Pregnant or breast-feeding woman 14) Who are enrolled in other clinical trials 15) Who cannot understand the purpose of the clinical trial or perform treatment protocol 16) Who is thought to be inappropriate to participate in the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 10-meter walking test | — |
Secondary
| Measure | Time frame |
|---|---|
| MMT(Manual muscle test);TUG(Timed up and go test);FAC(Functional Ambulatory Category);BBS(Berg balance test);K-MBI(K-Modified Barthel Index);European Quality of Life Five Dimension (EQ-5D-3L);Motor evoked potential | — |
Countries
Korea, Republic of
Contacts
Public ContactLee Jin-Seon
Chonnam National University Hospital
Outcome results
None listed